U.S. Department of Health & Human Services

06/11/2021 | Press release | Distributed by Public on 06/11/2021 04:32

COVID Data Tracker Recent Updates - 2021-06-10 - A new Nationwide Blood Donor Seroprevalence tab displays estimates of the percent of people with antibodies against SARS-CoV-2[...]

These data, gathered from blood donors, represent estimates of the percent of the U.S. population ages 16 and older that have developed antibodies against SARS-CoV-2, the virus that causes COVID-19, from vaccination or infection. This is known as seroprevalence. The nationwide blood donor seroprevalence survey will help in identifying the percentage of the U.S. population that has been infected with the virus or has developed antibodies after being vaccinated against COVID-19.